Product Program year 2025 Source: CMS Open Payments

LUTONIX Drug Coated Balloon

Device Vascular/Oncology

PDI 00801741199462

Open in the dashboard

General payments

$319,898

3,028 payments

Research payments

$0

0 payments

Through program year 2025, $319,898 in general payments and $0 in research payments were reported against LUTONIX Drug Coated Balloon (Vascular/Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $43,311 989
2024 General $230,232 1,182
2023 General $46,266 855
2022 General $89 2

Breakdown

Who paid General payments · program years 2022–2025
  1. C. R. Bard, Inc. & Subsidiaries $169,601 8 payments
  2. Bard Peripheral Vascular, Inc. $124,932 2,337 payments
  3. Becton, Dickinson and Company $25,112 677 payments
  4. Davol Inc. $253 6 payments
Top recipients General payments · program year 2025
  1. Corewell Health Wm. Beaumont Univ Teaching hospital · MI $1,500 3% · 1 payment
  2. Christopher Smolock Vascular Surgery · Astoria, NY $855 2% · 6 payments
  3. John Phair Vascular Surgery · Long Island City, NY $742 2% · 5 payments
  4. Surrender Raina Cardiovascular Disease · Stockton, CA $713 2% · 67 payments
  5. Jason Chiriano Vascular Surgery · Victorville, CA $651 2% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $13,931 34% · 165 practitioners
  2. Vascular & Interventional Radiology Radiology $6,292 15% · 99 practitioners
  3. Cardiovascular Disease Internal Medicine $4,010 10% · 39 practitioners
  4. Surgery $2,816 7% · 27 practitioners
  5. Diagnostic Radiology Radiology $2,621 6% · 49 practitioners

The top 5 of 34 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $9,501 22% · 85 recipients
  2. Michigan $5,113 12% · 50 recipients
  3. New York $3,658 8% · 38 recipients
  4. Texas $2,633 6% · 57 recipients
  5. Pennsylvania $2,546 6% · 40 recipients

The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

3,028 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record